Search details
1.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37589839
2.
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
Br J Cancer
; 119(9): 1060-1066, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30318511
3.
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579).
Breast Cancer Res Treat
; 151(3): 629-38, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-26006067
4.
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.
Eur Urol Oncol
; 7(3): 597-604, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38182487
5.
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling.
J Mol Diagn
; 24(12): 1254-1263, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36191839
6.
Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Cancers (Basel)
; 13(5)2021 Feb 24.
Article
in English
| MEDLINE | ID: mdl-33668244
Results
1 -
6
de 6
1
Next >
>>